2m 2m 2m 2m 2m 2m 2m
REZOLUTE (RZLT)
NASDAQ
$3.96-$0.11 (-2.63%)
Price as of Nov 12, 2026 9:42 AM EST- $393.7MMarket Cap
- -59.30%1-Year Change
- BiotechnologyIndustry
REZOLUTE (RZLT)
$3.96-$0.11 (-2.63%)
RZLT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.07 | ||
Change | +$0.05 (+1.24%) | ||
Open | $4.10 | ||
High | $4.16 | ||
Low | $3.99 | ||
Previous Close | $4.02 | ||
Volume | 974,249 | ||
30-Day Average Volume | 1,337,313 | ||
1-Week Change | 2.78% | ||
1-Month Change | -16.43% | ||
1-Year Change | -59.30% | ||
3-Year Change | 435.46% | ||
5-Year Change | -34.57% | ||
Fundamentals | |||
Shares Outstanding | 96.7M | ||
Total Assets | $96.0M | ||
Market Cap | $393.7M | ||
Enterprise Value | $385.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$18.5M | ||
Free Cash Flow | -$18.8M | ||
EBIT | -$18.5M | ||
EBITDA | -$18.5M | ||
Net Working Capital | $84.4M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -21 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -23 | ||
PEG | -3 | ||
Price/Free Cash Flow | -21 | ||
Price/Operating Cash Flow | -21 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 50 | ||
Last Split Date | 10/13/2020 | ||
Earnings & Revenue